Literature DB >> 25007095

Different tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice.

Hyunsook Park1, Norma V Solis2, James S Louie3, Brad Spellberg4, Natalie Rodriguez1, Scott G Filler4.   

Abstract

Tumor necrosis factor α is important for the host defense against intracellular pathogens. We tested the effect of mouse analogs of human TNF-α antagonists, the rat anti-mouse TNF-α monoclonal antibody (XT22) and the soluble mouse 75 kDa TNF-α receptor fused to the Fc portion of mouse IgG1 (p75-Fc), on the susceptibility of mice to hematogenously disseminated candidiasis (HDC) and oropharyngeal candidiasis (OPC). Both XT22 and p75-Fc significantly reduced mice survival, increased kidney fungal burden, and reduced leukocyte recruitment during HDC. However, only XT22 significantly increased the oral fungal burden and reduced leukocyte recruitment during OPC. This result suggests that XT22 and p75-Fc affect host susceptibility to different types of Candida albicans infections by different inhibitory mechanisms.

Entities:  

Keywords:  Candida albicans; hematogenously disseminated candidiasis; host susceptibility; murine model; oropharyngeal candidiasis; tumor necrosis factor antagonists

Mesh:

Substances:

Year:  2014        PMID: 25007095      PMCID: PMC4105312          DOI: 10.4161/viru.29699

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  21 in total

Review 1.  On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

2.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Mouse model of oropharyngeal candidiasis.

Authors:  Norma V Solis; Scott G Filler
Journal:  Nat Protoc       Date:  2012-03-08       Impact factor: 13.491

4.  Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.

Authors:  Sharon A McClellan; Xi Huang; Ronald P Barrett; Nico van Rooijen; Linda D Hazlett
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

5.  Induction of cytokine-induced neutrophil chemoattractant (CINC) mRNA in the lungs of septic rats.

Authors:  G C Lukaszewicz; W W Souba; S F Abcouwer
Journal:  J Trauma       Date:  1996-08

6.  Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.

Authors:  M G Netea; L J van Tits; J H Curfs; F Amiot; J F Meis; J W van der Meer; B J Kullberg
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

7.  Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Authors:  E Ricart; R Panaccione; E V Loftus; W J Tremaine; W J Sandborn
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

8.  Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro.

Authors:  Angela A Sanchez; Douglas A Johnston; Carter Myers; John E Edwards; Aaron P Mitchell; Scott G Filler
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions.

Authors:  B J Scallon; M A Moore; H Trinh; D M Knight; J Ghrayeb
Journal:  Cytokine       Date:  1995-04       Impact factor: 3.861

10.  Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

Authors:  Francisco M Marty; Stephanie J Lee; Michelle M Fahey; Edwin P Alyea; Robert J Soiffer; Joseph H Antin; Lindsey R Baden
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

View more
  4 in total

1.  Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus.

Authors:  Liana C Chan; Siyang Chaili; Scott G Filler; Lloyd S Miller; Norma V Solis; Huiyuan Wang; Colin W Johnson; Hong K Lee; Luis F Diaz; Michael R Yeaman
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

2.  The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney.

Authors:  Kritika Ramani; Abhishek V Garg; Chetan V Jawale; Heather R Conti; Natasha Whibley; Edwin K Jackson; Sruti S Shiva; William Horne; Jay K Kolls; Sarah L Gaffen; Partha S Biswas
Journal:  PLoS Pathog       Date:  2016-11-04       Impact factor: 6.823

3.  Tumor necrosis factor prevents Candida albicans biofilm formation.

Authors:  Francisco Airton Castro Rocha; Anelise Maria Costa Vasconcelos Alves; Marcos Fábio Gadelha Rocha; Rossana de Aguiar Cordeiro; Raimunda Sâmia Nogueira Brilhante; Ana Carolina Matias Dinelly Pinto; Rodolfo de Melo Nunes; Virgínia Cláudia Carneiro Girão; José Julio Costa Sidrim
Journal:  Sci Rep       Date:  2017-04-26       Impact factor: 4.379

4.  Treatment of Oral Candidiasis Using Photodithazine®- Mediated Photodynamic Therapy In Vivo.

Authors:  Juliana Cabrini Carmello; Fernanda Alves; Fernanda G Basso; Carlos Alberto de Souza Costa; Vanderlei Salvador Bagnato; Ewerton Garcia de Oliveira Mima; Ana Cláudia Pavarina
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.